Wellstar International Inc (WLSI)

Wellstar International Inc was formed in the State of Nevada on December 5, 1997. Through its wholly owned subsidiary, Trillennium Medical Imaging, Inc. (TMI), is developing and licensing the use of advanced thermal imaging technology. The TMI Infrared Technology and software is approved by the United States Food and Drug Administration (FDA) as an Adjunctive Diagnostic screening procedure for early breast cancer detection, differential diagnosis of pain dysfunctions, (such as Reflex Sympathetic Dystrophy, Neuromuscular Skeletal Syndromes and Neurological disorders), detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications. It is dedicated to placing cameras for a monthly charge in hospitals, clinical and long care facilities throughout the United States. It plans to grow in these markets by expanding its imaging capabilities by the constant acquisitions of new imaging technologies. The TMI Infrared Technology and software is approved by the FDA as an Adjunctive Diagnostic screening procedure for early breast cancer detection, differential diagnosis of pain dysfunctions, (such as Reflex Sympathetic Dystrophy, Neuromuscular Skeletal Syndromes and Neurological disorders), detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications. Markets such as University Research Centers, hospitals, multidisciplinary physician practices, pain centers, long term care facilities, home health care, and rehabilitation centers support the need for this type of screening modality.